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pinion  and  discussion
ype  1  diabetes  mellitus  in  Angolaiabetes mellitus tipo 1 em Angola
nselmo  de  Oliveira  Castela
línica Girassol, Luanda, AngolaDiabetes mellitus is a global epidemic and has emerged as a
ajor non-communicable chronic disease in Africa. Its incidence
nd prevalence are increasing globally. Estimates of WHO  and IDF
redict an increase of 162% by 2030 in Africa.3,4
There are few studies that assess the prevalence and incidence
f type 1 diabetes mellitus in Africa; from what is described type 1
iabetes mellitus in Africa seems to differ from Western countries
ince it starts later in life and there is some female preponder-
nce. Its incidence and prevalence are low.1,2 The prevalence is
ointed out to be 3.5/100,000 in Mozambique, Zambia 12/100,000
nd 3.5/100,000 in rural communities in South Africa and the
ncidence it is estimated to be 1.5/100,000/year in Tanzania and
.1/100,000/year in Ethiopia.1,4 In Angola, the data provided by the
pidemiological Data Processing Centre is scarce and not exten-
ive. We hope that the data update based on the population census
onducted in May  2014 and the work of the Angolan Society of
ndocrinology, Diabetes and Metabolism (to be launched soon)
t will be possible to obtain more information representing the
ngolan reality.
The Ministry of Health presented the National Health Devel-
pment Plan 2012–2025 (PNDS) which calls for designing a
rogramme for the Prevention and Control of Chronic Noncom-
unicable Diseases that Diabetes will be part.5 This is still in the
esign stage for further operation.
While waiting for the National Program for Diabetes Prevention
nd Control we should rely on the dedication and experience of
ealth professionals working with people with diabetes. Regarding
iabetes Mellitus type 1 it was found that: 1 – It is difﬁcult to
onﬁrm the diagnostic due to laboratory scarcity (immunological
ssays). 2 – Diabetic ketoacidosis has been the most frequent initial
anifestation.
3 – The arrival of patients to the Health services is often
elayed. This leads to late diagnosis and patient care, increas-
ng the risk of mortality. 4 – The Diabetic Association of Angola
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the fear of insulin dependence by patients and the fear of treat-
ing patients with insulin by physicians. 6 – Patients and their
families do not have enough information about the disease and
the need of chronic treatment), which compromises the compli-
ance. 7 – It should be taken into account the weight of traditional
medicine and popular beliefs. 8 – The difﬁcult access to insulin
due to high prices and storage difﬁculties) and to glycaemia self-
control makes treatment even more difﬁcult. Most people with
the disease have a low income and will need to choose between
paying for diabetes treatment or providing food for the family.
All these points contribute for hospital admissions for recur-
rence of diabetic ketoacidosis and for the high mortality of type
1 diabetes.
In this context it is proposed by the professionals that: 1
– It should be reinforced the need for a good health system
structure with formation of multidisciplinary teams in the var-
ious levels of care of persons with type 1 diabetes; 2 – It
should be given adequate training and information to patients
and professionals through educational sessions, symposia and
media support; 3 – The conditions for implementation of the
Programme for Prevention and Control of Diabetes should be cre-
ated; 4 – Government entities should be made aware of the need
of insulin reimbursement (the drug of survival) and self-control
procedures.
In short, the management of type 1 diabetes mellitus in Africa,
especially in Sub-Saharan region, is a major challenge given the
great limitations and constraints, cultural and economic, on access
to diagnosis and treatment. This contributes to increased morbidity
and mortality associated with the disease and its complications.
This situation is worsened by the prevalence and predisposition to
several infections (tuberculosis, malaria, HIV-AIDS, etc.). There is
an urgent need for training of professionals, education of patients
and improvement of the Health System organization.1–5
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